Hiroshi Katayama

10.8k total citations · 1 hit paper
223 papers, 6.6k citations indexed

About

Hiroshi Katayama is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroshi Katayama has authored 223 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 80 papers in Oncology and 48 papers in Surgery. Recurrent topics in Hiroshi Katayama's work include Gastric Cancer Management and Outcomes (73 papers), Gastrointestinal Tumor Research and Treatment (33 papers) and Metastasis and carcinoma case studies (32 papers). Hiroshi Katayama is often cited by papers focused on Gastric Cancer Management and Outcomes (73 papers), Gastrointestinal Tumor Research and Treatment (33 papers) and Metastasis and carcinoma case studies (32 papers). Hiroshi Katayama collaborates with scholars based in Japan, United States and Netherlands. Hiroshi Katayama's co-authors include Subrata Sen, Junki Mizusawa, Fumio Suzuki, William R. Brinkley, Masaaki Tatsuka, Mitsuru Sasako, Kaori Sasai, Haruhiko Fukuda, Yasuhiko Terada and Masanori Terashima and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Katayama

213 papers receiving 6.4k citations

Hit Papers

Extended Clavien-Dindo classification of surgical complic... 2015 2026 2018 2022 2015 200 400 600

Peers

Hiroshi Katayama
Yeul Hong Kim South Korea
Susan C. Abraham United States
Se Jin Jang South Korea
Steven N. Hochwald United States
Andrew C. Chang United States
Hiroshi Katayama
Citations per year, relative to Hiroshi Katayama Hiroshi Katayama (= 1×) peers Satoshi Kondo

Countries citing papers authored by Hiroshi Katayama

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Katayama more than expected).

Fields of papers citing papers by Hiroshi Katayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Katayama. The network helps show where Hiroshi Katayama may publish in the future.

Co-authorship network of co-authors of Hiroshi Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Katayama. A scholar is included among the top collaborators of Hiroshi Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Katayama. Hiroshi Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nakachi, Kohei, Masafumi Ikeda, Masaru Konishi, et al.. (2024). Adjuvant S-1 vs. observation for resected biliary tract cancer: 5-year follow-up of the JCOG1202/ASCOT.. Journal of Clinical Oncology. 42(16_suppl). 4119–4119. 1 indexed citations
3.
Iwamoto, Shin, Kenneth J. Cavanaugh, Misti Malone, et al.. (2023). Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct. Cardiovascular revascularization medicine. 52. 67–74. 2 indexed citations
4.
Kunisaki, Chikara, Hitoshi Katai, Shinichi Sakuramoto, et al.. (2023). A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401. Gastric Cancer. 27(1). 164–175. 10 indexed citations
5.
Kanemitsu, Yukihide, Kohei Shitara, Junki Mizusawa, et al.. (2021). Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. Journal of Clinical Oncology. 39(10). 1098–1107. 115 indexed citations
6.
Sato, Yuya, Junki Mizusawa, Hiroshi Katayama, et al.. (2020). Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A. European Journal of Surgical Oncology. 46(6). 1074–1079. 11 indexed citations
8.
Li, Zehuan, Xiaomeng He, Zhanghan Chen, et al.. (2020). Identification of Specific Long Non-Coding Ribonucleic Acid Signatures and Regulatory Networks in Prostate Cancer in Fine-Needle Aspiration Biopsies. Frontiers in Genetics. 11. 62–62. 13 indexed citations
9.
Miyamoto, Ken‐ichi, Atsuo Takashima, Junki Mizusawa, et al.. (2019). Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial). Japanese Journal of Clinical Oncology. 49(10). 985–990. 6 indexed citations
10.
Yasuda, Yukiko, Akiko Sakai, Sachio Ito, et al.. (2017). Human RAD 17 Polymorphism at Codon 546 Is Associated with the Risk of Colorectal Cancer.. PubMed. 71(1). 59–68. 3 indexed citations
11.
Ohashi, Masaki, Makoto Saka, Hiroshi Katayama, et al.. (2015). A Prospective Cohort Study To Evaluate the Feasibility of Intraoperative Antimicrobial Prophylaxis in Open Gastrectomy for Gastric Cancer. Surgical Infections. 16(6). 833–839. 4 indexed citations
12.
Inomata, Masafumi, Tomonori Akagi, Hiroshi Katayama, et al.. (2014). A Randomized Controlled Trial Comparing Laparoscopic Surgery with Open Surgery in Palliative Resection of Primary Tumor in Incurable Stage IV Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE Trial). Japanese Journal of Clinical Oncology. 44(11). 1123–1126. 3 indexed citations
13.
Katai, Hitoshi, Hiroharu Yamashita, Masaki Ohashi, et al.. (2013). HER2 Expression in Carcinomas of the True Cardia (Siewert Type II Esophagogastric Junction Carcinoma). World Journal of Surgery. 38(2). 426–430. 6 indexed citations
14.
Morimatsu, Hiroshi, Moritoki Egi, Kazuyoshi Shimizu, et al.. (2011). . Journal of the Japanese Society of Intensive Care Medicine. 18(2). 215–220. 2 indexed citations
15.
Torchia, Enrique C., Yiyun Chen, Hiroshi Katayama, et al.. (2009). A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors. Cancer Research. 69(18). 7207–7215. 29 indexed citations
16.
Katayama, Hiroshi, et al.. (2005). A Case of Multisaccular Thoracic Aortic Aneurysm Associated with Coarctation of the Aorta. Japanese Journal of Cardiovascular Surgery. 34(5). 370–373.
17.
Katayama, Hiroshi, et al.. (2002). "Effects of carbonizing conditions on the specific surface area of charcoal from sugi (Cryptomeria japonica) wood, 2: Effects of carbonizing temperature and carbon dioxide concentration in carbonizing atmospheres.". Journal of the Japan Wood Research Society. 3 indexed citations
18.
Katayama, Hiroshi, et al.. (2001). The effect of carbonizing conditions on the specific surface area of charcoal from sugi (Cryptomeria japonica) wood. Journal of the Japan Wood Research Society. 2 indexed citations
19.
Katayama, Hiroshi, et al.. (1996). Formation of Alloyed Layer on Steel Surface by Immersion into Molten Aluminum Alloys. Journal of Japan Foundry Engineering Society. 68(11). 975–980. 1 indexed citations
20.
Katayama, Hiroshi, et al.. (1996). Diffusion Bonding of High Chromium Cast Iron to Cast Steel in Air. Journal of Japan Foundry Engineering Society. 68(1). 43–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026